Qinghai Biotech Pharmaceutical Group Limited (HKG:0876)

HKG:0876 Revenue

Qinghai Biotech Pharmaceutical Group had revenue of 284.59M HKD in the half year ending June 30, 2026, with 221.51% growth. This brings the company's total for the last twelve months to 85.50M, down -80.35% year-over-year. In the year 2025, Qinghai Biotech Pharmaceutical Group had annual revenue of 139.11M, down -24.95%. That makes Qinghai Biotech Pharmaceutical Group the 36,914th largest company in the world by revenue and 2,246th in Hong Kong.

• Revenue (ttm): 85.50M
• Revenue Growth: -80.35%
• P/S Ratio: 1.77
• Revenue / Employee: 63.81K
• Employees: 1,340
• Market Cap: 151.30M

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Dental Business 132.03M 94.9%
• Health Care Business 7.08M 5.1%

Fiscal year ended Dec 31, 2025 See the full HKG:0876 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	139.11M	-46.25M	-24.95%
Dec 31, 2024	185.36M	-525.00K	-0.28%
Dec 31, 2023	185.88M	-5.62M	-2.93%
Dec 31, 2022	191.50M	-18.13M	-8.65%
Dec 31, 2021	209.63M	25.82M	14.04%

Data Source: S&P Global Market Intelligence Last updated: Sep 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 22, 2026

Data Sources Report a data error